Voyageur Pharmaceuticals (CVE:VM) Shares Down 31.3% – Here’s Why

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report) shares were down 31.3% during trading on Thursday . The company traded as low as C$0.14 and last traded at C$0.17. Approximately 1,643,425 shares were traded during mid-day trading, an increase of 198% from the average daily volume of 550,572 shares. The stock had previously closed at C$0.24.

Voyageur Pharmaceuticals Trading Down 10.0 %

The stock has a 50 day moving average of C$0.11 and a 200-day moving average of C$0.08. The company has a market capitalization of C$25.10 million, a P/E ratio of -18.00 and a beta of 0.32. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Articles

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.